| Trial Identifier: | D601HC00009 |
| Sponsor: | AstraZeneca |
| Collaborator: |
Parexel
|
| NCTID:: | NCT04949425 |
| Start Date: | September 2021 |
| Primary Completion Date: | April 2022 |
| Study Completion Date: | April 2022 |
| Condition: | Cancer - Other |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
| Language | Description |
| English Version | |
| English (UK) Translation | |
| Spanish (Spain) Translation | |
| Spanish (US) Translation |
| Country | Location |
|---|---|
| GB | Manchester, GB, M20 4BX |
| US, TX | Dallas, TX, US, 75230 |
Powered by
Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.
Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company